SI
CLB icon

Scout Investments’s Core Laboratories CLB Stock Holding History

Scout Investments’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$4.27M Sell
221,215
-35,778
-14% -$718K 0.11% 179
2024
Q2 		$5.21M Sell
256,993
-24,617
-9% -$436K 0.14% 176
2024
Q1 		$4.82M Sell
281,610
-121
-0% -$1.9K 0.12% 184
2023
Q4 		$4.98M Sell
281,731
-4,418
-2% -$89K 0.12% 188
2023
Q3 		$6.68M Sell
286,149
-8,305
-3% -$204K 0.15% 167
2023
Q2 		$7.3M Sell
294,454
-8,749
-3% -$198K 0.15% 171
2023
Q1 		$6.69M Sell
303,203
-3,589
-1% -$84K 0.14% 169
2022
Q4 		$6.22M Buy
306,792
+21,164
+7% +$410K 0.13% 173
2022
Q3 		$3.85M Sell
285,628
-7,981
-3% -$134K 0.08% 205
2022
Q2 		$5.82M Buy
293,609
+92,228
+46% +$2.45M 0.12% 180
2022
Q1 		$6.37M Buy
201,381
+106,302
+112% +$2.98M 0.1% 191
2021
Q4 		$2.12M Sell
95,079
-2,147
-2% -$56K 0.03% 291
2021
Q3 		$2.7M Buy
97,226
+25,252
+35% +$769K 0.04% 293
2021
Q2 		$2.8M Sell
71,974
-6,045
-8% -$217K 0.04% 253
2021
Q1 		$2.25M Buy
78,019
+7,782
+11% +$266K 0.03% 301
2020
Q4 		$1.86M Buy
70,237
+1,521
+2% +$31.1K 0.03% 303
2020
Q3 		$1.05M Sell
68,716
-1,630
-2% -$34.2K 0.02% 307
2020
Q2 		$1.43M Buy
70,346
+119
+0.2% +$2.13K 0.03% 298
2020
Q1 		$726K Sell
70,227
-3,478
-5% -$97.3K 0.02% 285
2019
Q4 		$2.78M Sell
73,705
-1,100
-1% -$49.4K 0.05% 267
2019
Q3 		$3.49M Sell
74,805
-6,121
-8% -$285K 0.07% 236
2019
Q2 		$4.23M Buy
80,926
+32,123
+66% +$1.88M 0.08% 216
2019
Q1 		$3.36M Buy
+48,803
New +$3.27M 0.07% 217
2014
Q4 		– Sell
-1,398
Closed -$205K – 284
2014
Q3 		$205K Hold
1,398
– – ﹤0.01% 274
2014
Q2 		$234K Buy
1,398
+238
+21% +$42.3K ﹤0.01% 269
2014
Q1 		$230K Sell
1,160
-404
-26% -$76.3K ﹤0.01% 261
2013
Q4 		$299K Sell
1,564
-152
-9% -$28.3K ﹤0.01% 267
2013
Q3 		$290K Hold
1,716
– – ﹤0.01% 353
2013
Q2 		$260K Buy
+1,716
New +$243K ﹤0.01% 256

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Scout Investments's CLB Position: Q3 2024 in Review

Scout Investments reduced its Core Laboratories (CLB) stake by 14% in Q3 2024, selling an estimated $718K and leaving 221,215 shares worth $4.27M. The position accounts for 0.11% of the portfolio, ranked #179.

Scout Investments first reported a position in CLB in Q2 2013 and has held it in 29 quarters since. The position peaked at $7.3M in Q2 2023. 191 funds tracked by Wall St. Rank hold CLB as of Q3 2024.

  • Scout Investments held 221,215 shares of Core Laboratories worth $4.27M as of Q3 2024.
  • Scout Investments sold 35,778 Core Laboratories shares in Q3 2024, an estimated $718K.
  • Core Laboratories made up 0.11% of Scout Investments's portfolio in Q3 2024, its #179 holding.
  • Scout Investments first reported a position in Core Laboratories in Q2 2013 and has held it in 29 quarters since.
  • Scout Investments's Core Laboratories position peaked at $7.3M in Q2 2023.
  • 191 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2024.

Based on Scout Investments's 13F filing for Q3 2024, filed 12 Nov 2024.